arformoterol (RR formoterol) + placebo + levalbuterol
ApprovedTerminated 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Acute Asthma
Conditions
Acute Asthma
Trial Timeline
Jan 1, 2009 → Nov 1, 2009
NCT ID
NCT00819637About arformoterol (RR formoterol) + placebo + levalbuterol
arformoterol (RR formoterol) + placebo + levalbuterol is a approved stage product being developed by Sumitomo Pharma for Acute Asthma. The current trial status is terminated. This product is registered under clinical trial identifier NCT00819637. Target conditions include Acute Asthma.
What happened to similar drugs?
20 of 20 similar drugs in Acute Asthma were approved
Approved (20) Terminated (3) Active (0)
✅Modification of Prasugrel based on a biological assay + prasugrel / clopidogrelDaiichi SankyoApproved
Hype Score Breakdown
Clinical
20
Activity
0
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00819637 | Approved | Terminated |
Competing Products
20 competing products in Acute Asthma